Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Examination of ACT Strategy in South-central Asia on Falciparum Malaria in a Context Where Vivax is the Major Species

NCT00935688 is registered in ClinicalTrials.gov with London School of Hygiene and Tropical Medicine as lead sponsor.

NCT NCT00935688
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00935688 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Examination of ACT Strategy in South-central Asia on Falciparum Malaria in a Context Where Vivax is the Major Species
Lead sponsor
London School of Hygiene and Tropical Medicine
Phase
Phase 4
Overall status
Completed
Start date
May 31, 2009
Completion date
October 31, 2010
Enrollment
4,200 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

fever, malaria